Knott David M Jr Inozyme Pharma, Inc. Transaction History
Knott David M Jr
- $283 Million
- Q1 2024
A detailed history of Knott David M Jr transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Knott David M Jr holds 564,549 shares of INZY stock, worth $2.72 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
564,549
Previous 564,549
-0.0%
Holding current value
$2.72 Million
Previous $2.41 Million
79.79%
% of portfolio
1.53%
Previous 0.92%
Shares
4 transactions
Others Institutions Holding INZY
# of Institutions
92Shares Held
49MCall Options Held
1.6KPut Options Held
22K-
Adage Capital Partners Gp, L.L.C. Boston, MA5.33MShares$25.7 Million0.08% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA4.49MShares$21.7 Million25.25% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA4.28MShares$20.6 Million1.91% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3.68MShares$17.7 Million0.74% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.18MShares$15.3 Million0.39% of portfolio
About Inozyme Pharma, Inc.
- Ticker INZY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,145,700
- Market Cap $194M
- Description
- Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...